The Journal of Practical Medicine >

2026 , Vol. 42 >Issue 15: 2808 - 2816

DOI: https://doi.org/10.3969/j.issn.1006-5725.2026.15.017

Treatise：Mechanism and Practice

Buyang Huanwu Decoction attenuates ligamentum flavum fibrosis by regulating the PHLPP1/AKT/mTORC1 signaling pathway

  • Datian WANG ,
  • Zhiwei ZHANG ,
  • Guanghua LI ,
  • Kan CHEN ,
  • Linqi WANG ,
  • Tingting XU ,
  • Min SHAO
Expand
  • 1.The Third School of Clinical Medicine，Guangzhou University of Chinese Medicine，Guangzhou 510000，Guangdong，China
    2.Hainan Hospital，Guangdong Provincial Hospital of Chinese Medicine，Haikou 570100，Hainan，China
    3.Department of Orthopedics，928th Hospital of PLA Joint Logistics Support Force，Haikou 570100，Hainan，China
    4.Shunde Hospital of Guangzhou University of Chinese Medicine，Foshan 528000，Guangdong，China

Received date: 2026-06-03

  Revised date: 2026-06-14

  Accepted date: 2026-06-15

  Online published: 2026-08-13

Fold

Abstract

Objective To investigate the effects of Buyang Huanwu Decoction （BYHWD） on the abnormal proliferation and fibrosis of human ligamentum flavum cells （LFCs） induced by transforming growth factor-β1 （TGF-β1）， and to elucidate the underlying molecular mechanisms mediated by the PHLPP1/AKT/mTORC1 signaling pathway. Methods Primary human LFCs were cultured in vitro and stimulated with TGF-β1 to establish a fibrotic cell model， followed by intervention with BYHWD-medicated serum. Cell proliferation was assessed using CCK-8 and EdU assays. Western blotting was performed to detect the protein expression levels of proliferation-related markers （PCNA， Ki-67）， fibrosis-related markers （collagen Ⅰ， collagen Ⅲ， α-SMA， and fibronectin）， and key signaling proteins （PHLPP1， p-AKT， total AKT， p-S6K， total S6K， p-S6， and total S6）. Furthermore， a lentiviral vector carrying shPHLPP1 was constructed to perform PHLPP1 knockdown rescue experiments， thereby verifying the pathway dependence of BYHWD efficacy. Results BYHWD-medicated serum markedly suppressed TGF-β1-induced proliferation of LFCs and downregulated the expression of PCNA and Ki-67. Concurrently， BYHWD reduced the protein levels of collagen I， collagen III， α-SMA， and fibronectin， thereby alleviating cellular fibrosis. Mechanistically， BYHWD upregulated PHLPP1 expression and decreased the ratios of phosphorylated to total proteins （p-AKT/AKT， p-S6K/S6K， and p-S6/S6）， thus blocking the hyperactivation of the AKT/mTORC1 cascade. Notably， PHLPP1 knockdown significantly reversed the inhibitory effects of BYHWD on cell proliferation and fibrosis， as well as its suppressive effect on the AKT/mTORC1 pathway. Conclusions BYHWD attenuates the aberrant proliferation and fibrosis of LFCs by upregulating PHLPP1 and suppressing the hyperactivation of the AKT/mTORC1 signaling pathway. This study provides experimental evidence and identifies potential molecular targets for the clinical application of BYHWD in treating ligamentum flavum hypertrophy and lumbar spinal stenosis associated with Qi deficiency and blood stasis syndrome.

Key words： Buyang Huanwu Decoction; ligamentum flavum; PHLPP1; fibrosis

Cite this article

Datian WANG , Zhiwei ZHANG , Guanghua LI , Kan CHEN , Linqi WANG , Tingting XU , Min SHAO . Buyang Huanwu Decoction attenuates ligamentum flavum fibrosis by regulating the PHLPP1/AKT/mTORC1 signaling pathway[J]. The Journal of Practical Medicine, 2026 , 42(15) : 2808 -2816 . DOI: 10.3969/j.issn.1006-5725.2026.15.017

References

[1] ZHAO Y， XIANG Q， TIAN S， et al. Noncoding RNA as a crucial epigenetic modulator in the degeneration of the ligamentum flavum ［J］. Exp Mol Med， 2024， 56（12）： 2551-2558.doi：10.1038/s12276-024-01348-2 .
[2] KATZ J N， ZIMMERMAN Z E， MASS H， et al. Diagnosis and management of lumbar spinal stenosis： A review ［J］. JAMA， 2022， 327（17）： 1688-1699.doi：10.1001/jama.2022.5921 .
[3] SHI H X， GAO Y J， WANG S R. Electroacupuncture in non-surgical management of lumbar spinal stenosis： Mechanistic potential in attenuating ligamentum flavum thickening via inflammatory factor modulation ［J］. Front Immunol， 2025， 16： 1644394.doi：10.3389/fimmu.2025.1644394 .
[4] 陈耀鑫， 黎松波， 方冠军， 等. 黄韧带中成纤维细胞生长因子1、血管内皮生长因子表达与腰椎管狭窄患者腰椎减压术后再狭窄的关系 ［J］. 实用医学杂志， 2023， 39（18）： 2289-2293.doi： 10.3969/j.issn.1006-5725.2023.18.001 .
[5] SILWAL P， NGUYEN-THAI A M， ALEXANDER P G， et al. Cellular and molecular mechanisms of hypertrophy of ligamentum flavum ［J］. Biomolecules， 2024， 14（10）：1277.doi：10.3390/biom14101277 .
[6] 张友， 陈弘林， 刘宇， 等. 肉豆蔻酸延缓黄韧带成纤维细胞/骨髓间充质干细胞衰老调控成骨的机制 ［J］. 中国骨质疏松杂志， 2025， 31（10）： 1413?1421.doi： 10.3969/j.issn.1006-7108. 2025.10.002 .
[7] 彭天忠， 黄学娣， 林星镇， 等. 开窍醒神针法联合加味补阳还五汤对脑出血恢复期患者（气虚血瘀证）IL-2、MMP-9、BDNF及脑血流量的影响 ［J］. 实用医学杂志， 2025， 41（3）： 428-433.doi：10.3969/j.issn.1006-5725.2025.03.019 .
[8] 黄婷婷， 吴海科， 练梦结， 等. 不同频率重复经颅磁刺激联合补阳还五汤对气虚血瘀型卒中患者运动功能的疗效观察 ［J］. 实用医学杂志， 2023， 39（4）： 499?504.doi：10.3969/j.issn. 1006-5725.2023.04.020 .
[9] WANG L， MA J， CHEN C， et al. Isoquercitrin alleviates pirarubicin-induced cardiotoxicity in vivo and in vitro by inhibiting apoptosis through Phlpp1/AKT/Bcl-2 signaling pathway ［J］. Front Pharmacol， 2024， 15： 1315001.doi：10.3389/fphar.2024. 1315001 .
[10] ZHAO R， DONG J， LIU C， et al. Thrombospondin-1 promotes mechanical stress-mediated ligamentum flavum hypertrophy through the TGFβ1/Smad3 signaling pathway ［J］. Matrix Biol， 2024， 127： 8-22.doi：10.1016/j.matbio.2024.01.005 .
[11] DONG J， CAO Y， CHEN X， et al. Buyang Huanwu Decoction promotes neurorepair after spinal cord injury through a Lactobacillus johnsonii-indole-3-lactic acid-AhR-PI3K/Akt axis ［J］. Chin Med， 2026， 21（1）：129.doi：10.1186/s13020-026-01408-x .
[12] ZHANG C， JOSEPH K M， KHAN N M， et al. PHLPP1 deficiency protects against age-related intervertebral disc degeneration ［J］. JOR Spine， 2022， 5（4）： e1224.doi：10.1002/jsp2.1224 .
[13] YAN B， ZENG C， CHEN Y， et al. Mechanical Stress-Induced IGF-1 Facilitates col-I and col-Ⅲ Synthesis via the IGF-1R/AKT/mTORC1 Signaling Pathway ［J］. Stem Cells Int， 2021， 2021： 5553676.doi：10.1155/2021/5553676 .
[14] CHUANG H C， TSAI K L， TSAI K J， et al. Oxidative stress mediates age-related hypertrophy of ligamentum flavum by inducing inflammation， fibrosis， and apoptosis through activating Akt and MAPK pathways ［J］. Aging （Albany NY）， 2020， 12（23）： 24168?24183.doi：10.18632/aging.104105 .
[15] NAKAJIMA H， JOHNSON W E B， KAMITANI M， et al. Proteomic analysis and effects on osteogenic differentiation of exosomes from patients with ossification of the spinal ligament ［J］. JBMR Plus， 2025， 9（4）： ziaf021.doi：10.1093/jbmrpl/ziaf021 .
[16] WANG H F， KUANG M J， HAN S J， et al. Correction to： BMP2 Modified by the m6A Demethylation Enzyme ALKBH5 in the Ossification of the Ligamentum Flavum Through the AKT Signaling Pathway ［J］. Calcif Tissue Int， 2024， 114（5）：556-557. doi：10.1007/s00223-024-01206-3 .
[17] BAFFI T R， COHEN-KATSENELSON K， NEWTON A C. PHLPPing the Script： Emerging Roles of PHLPP Phosphatases in Cell Signaling ［J］. Annu Rev Pharmacol Toxicol， 2021， 61： 723-743.doi：10.1146/annurev-pharmtox-031820-122108 .
[18] COHEN KATSENELSON K， STENDER J D， KAWASHIMA A T， et al. PHLPP1 counter-regulates STAT1-mediated inflammatory signaling ［J］. Elife， 2019， 8：e48609. doi： 10.7554/eLife. 48609 .
[19] LUPSE B， ANNAMALAI K， IBRAHIM H， et al. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes ［J］. Cell Rep， 2021， 36（5）： 109490.doi：10.1016/j.celrep. 2021.109490 .
[20] HU C， QIAO W， LI X， et al. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8（+）T cells ［J］. Cell Metab， 2024， 36（3）： 630-647.doi：10.1016/j.cmet.2024.01.005 .
[21] CAI J， YE Z， HU Y， et al. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma ［J］. Cell Death Dis， 2023， 14（3）： 211.doi：10.1038/s41419-023-05738-8 .
Options
Outlines

/

〈 〉